Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Active not recruiting × Ipilimumab × Clear all

Phase

Phase 2 63 Phase 1 19 Phase 3 14 Phase 1/2 14 Phase EARLY_PHASE1 3 Phase 2/3 2 Phase 4 1

Status

Completed 3 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Melanoma 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 5 Dexamethasone 3 Cisplatin 3 human papillomavirus vaccine, L1 type 16, 18 2 adacel 2 Tobacco Use Cessation Devices 2 Tetanus Toxoid 2 Prednisone 2 Papillomavirus Vaccines 2 Letrozole 2 Diphtheria-Tetanus-acellular Pertussis Vaccines 2 Diphtheria Toxoid 2 Denosumab 2 Carboplatin 2 Cannabidiol 2 Atorvastatin 2 Anesthesia, Epidural 2 xiapex 1 venetoclax 1 trametinib 1 tirbanibulin 1 tenofovir alafenamide 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 ribociclib 1 rasburicase 1 pembrolizumab 1 pasireotide 1 nimotuzumab 1 mogamulizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02068196 2023-03-24

Ipi4

Oslo University Hospital

Phase 4 Active not recruiting

Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡